SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MorphoSys AG (MOR) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (15)10/23/2002 4:41:43 AM
From: nigel bates  Respond to of 421
 
FRANKFURT -(Dow Jones)- MorphoSys AG , the Munich-based biotechnology company, today announced that it has terminated merger talks with British Biotech plc.
MorphoSys also updated its guidance regarding strategic equity-based partnerships.
The Company advised that it does not expect such a transaction to be completed in the current calendar year, and revised its expected year-end cash position down to approximately EUR15 million...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News